article thumbnail

Ascending Aorta & Aortic Root Surgery Risk Calculator

Society of Thoracic Surgeons - Congenital

Resource Ascending Aorta & Aortic Root Surgery Risk Calculator gmckinney Fri, 04/25/2025 - 08:08 Aortic operations accounted for about 11% of all major cardiac surgeries in the United States in 2024, up from 8.3% Image Adult Cardiac Clinical Decision-Making Database Patient Outcomes Quality Improvement Use the Calculator

Aortic 52
article thumbnail

Surgical and transcatheter aortic valve interventions for aortic stenosis in England: sociodemographic variations in treatment trends and outcome over 20 years

Heart BMJ

The sociodemographic characteristics of patients undergoing intervention for aortic stenosis (AS) in England, and the impact of COVID-19, is unknown. Background Health inequalities in cardiovascular care have been identified in the UK.

article thumbnail

TAVR System Shows Durable Clinical Outcomes, Strong Valve Performance in Low-Risk Aortic Stenosis Patients

DAIC

tim.hodson Mon, 03/31/2025 - 15:39 March 30, 2025 Medtronic has announced late-breaking data on five-year outcomes from the Evolut Low Risk Trial. Two-Year Outcomes of the Five-Year SMART Trial, presented at CRT 2025. Reardon, M.D., Additional findings at five years include: Numerically lower rate of cardiovascular mortality (7.2%

TAVR 52
article thumbnail

Altshock-2: Early IABP Implantation Does Not Improve Outcomes For HF-CS

American College of Cardiology

Implantation of an intra-aortic balloon pump (IABP) did not improve 60-day survival or bridge to heart replacement (HRT) therapies in patients with heart failure-cardiogenic shock (HF-CS) compared to standard care, according to a study presented during a Featured Clinical Research session at ACC.25

article thumbnail

Management of bicuspid aortic valve disease in the transcatheter aortic valve implantation era

Heart BMJ

In an era of rapidly expanding use of transcatheter aortic valve implantation (TAVI), the management of patients with bicuspid aortic valve (BAV) disease is far less well established than in those with trileaflet anatomy.

article thumbnail

Optimal antithrombotic therapy after transcatheter aortic valve replacement: a comprehensive review

Frontiers in Cardiovascular Medicine

Transcatheter aortic valve replacement (TAVR) has become a leading treatment for aortic stenosis, but managing thromboembolic and bleeding risks post-procedure remains challenging. This review examines current evidence on antithrombotic therapy after TAVR.

article thumbnail

Early and late clinical outcomes and cost-effectiveness of aortic valve replacement using the Inspiris Resilia bioprosthesis

Journal of Cardiothoracic Surgery

Background The present study aimed to critically revise the published literature on clinical outcomes and cost-effectiveness of Inspiris Resilia valve. Studies were excluded if they weren’t exclusively conducted on patients submitted to surgical aortic valve replacement using the Inspiris Resilia bioprosthesis.